Introduction: Shanghai Antibee Pioneer Pharmaceutical Co., Ltd. is a joint venture company established by Shanghai New Pioneer Pharmaceutical Co., Ltd. and Italy Antibee Co., Ltd., located in Zhangjiang High-tech Development Zone, Shanghai. Introduce a full set of foreign advanced production technology to produce potassium clavulanate and its compound drug with amoxicillin, sterile raw material powder of potassium clavulanate and amoxicillin compound drug, solid preparation of potassium clavulanate and amoxicillin compound drug and other products. For both Chinese and foreign parties, the registered capital is140,000 USD. Shanghai Antibiotic Pioneer Pharmaceutical Co., Ltd. produces 80 tons of potassium clavulanate and 450 tons of compound drugs of potassium clavulanate and amoxicillin. Italian antibiotic company is a world-famous antibiotic production group, which has been developing in China market for more than 20 years. In addition to Shanghai Antibiotic Pioneer Pharmaceutical Co., Ltd., cephalosporin raw materials produced by another joint venture factory are also at the leading level in the same industry. "New Pioneer" is the largest antibiotic group in Shanghai with a registered capital of 654.38 billion yuan. At present, the annual industrial output value is 654.38 billion yuan, and the sales volume is nearly 3 billion yuan. Pioneer Pharmaceutical, one of the "new pioneers", is the first professional antibiotic manufacturer in China, which was established in 195 1. Known as the cradle of antibiotics in China, it gave birth to the first penicillin and the first semi-synthetic antibiotic in China. Potassium clavulanate is a powerful and broad-spectrum β -lactamase inhibitor, which can inhibit β -lactamase produced by staphylococcus and most gram-negative bacteria, thus inhibiting the decomposition of β -lactam antibiotics and destroying the drug resistance of bacteria. It can be used for injection and oral administration. Amoxicillin/potassium clavulanate is a compound drug composed of potassium clavulanate and amoxicillin, which has high sensitivity to pathogenic bacteria and low minimum inhibitory concentration. These drugs are clinically used to treat various infections such as lower respiratory tract, urinary tract, hematological diseases, tumors and digestive tract. The incidence of adverse reactions was low and mild, and disappeared immediately after stopping taking the drug. It is an effective, safe, broad antibacterial spectrum and low drug resistance.
Legal Representative: Lu Jianguo.
Established: 1996-03- 18
Registered capital: 654.38+0.4 million USD.
Industrial and commercial registration number: 310115400036285
Type of enterprise: limited liability company (Taiwan, Hong Kong and Macao joint venture)
Company Address: No.92, Zhangjiang Road, China (Shanghai) Pilot Free Trade Zone